{"id":1574,"date":"2020-07-17T02:44:58","date_gmt":"2020-07-17T02:44:58","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=1574"},"modified":"2023-08-29T18:02:01","modified_gmt":"2023-08-29T18:02:01","slug":"imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=1574","title":{"rendered":"Imugene\u83b7\u5f97\u4e86\u65b0\u7684\u764c\u75c7\u514d\u75ab\u7597\u6cd5PD1-Vaxx\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53cc\u91cd\u6279\u51c6"},"content":{"rendered":"<p>\u514d\u75ab\u80bf\u7624\u516c\u53f8<a href=\"http:\/\/smallcaps-production.test\/stocks\/?symbol=IMU&amp;lang=cn\">Imugene (ASX: IMU)<\/a>\u53ca\u65f6\u83b7\u5f97\u4e86\u7b2c\u4e8c\u5c4a\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a(HREC)\u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u5f00\u59cb\u5176\u68c0\u67e5\u70b9\u514d\u75ab\u7597\u6cd5\u5019\u9009\u4ea7\u54c1PD1-Vaxx\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p>\u5c31\u5728\u4e09\u5929\u524d\uff0c\u8be5\u516c\u53f8\u5ba3\u5e03\u6536\u5230HREC\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u9996\u4efd\u6279\u51c6\uff0c\u8be5\u8bd5\u9a8c\u5c06\u5728\u6089\u5c3c\u7efc\u5408\u764c\u75c7\u533b\u9662Chris O &#8216;Brien Lifehouse\u8fdb\u884c\u3002<\/p>\n<p>\u7b2c\u4e8c\u5bb6\u83b7\u5f97\u4f26\u7406\u8bb8\u53ef\u7684\u533b\u9662\u662f\u540c\u6837\u4f4d\u4e8e\u6089\u5c3c\u7684\u9ea6\u8003\u745e\u5927\u5b66\u533b\u9662\u3002Imugene\u8868\u793a\uff0c\u968f\u7740\u8be5\u516c\u53f8\u6700\u8fd1\u5411\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(Food and Drug Administration)\u63d0\u4ea4\u4e86\u65b0\u836f\u7814\u7a76\u62a5\u544a\uff0c\u516c\u53f8\u5f88\u5feb\u5c06\u5728\u6fb3\u5927\u5229\u4e9a\u548c\u7f8e\u56fd\u5f00\u8bbe\u66f4\u591a\u7684\u4e34\u5e8a\u57fa\u5730\u3002<\/p>\n<p>\u8fd9\u7b14\u8d44\u91d1\u610f\u5473\u7740Imugene\u5df2\u7ecf\u6210\u529f\u901a\u8fc7\u4e86\u4f26\u7406\u5ba1\u6279\uff0c\u5e76\u8bc1\u5b9e\u8be5\u516c\u53f8\u5df2\u7ecf\u5b8c\u6210\u4e86PD1-Vaxx\u6240\u6709\u4f18\u79c0\u7684\u4e34\u5e8a\u524d\u5b89\u5168\u548c\u6709\u6548\u6027\u6d4b\u8bd5\uff0c\u53ef\u4ee5\u5f00\u59cb\u4eba\u4f53\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p>I\u671f\u8bd5\u9a8c\u7684\u6fb3\u5927\u5229\u4e9a\u90e8\u5206\u5c06\u6309\u7167\u6fb3\u5927\u5229\u4e9a\u7684\u4e34\u5e8a\u8bd5\u9a8c\u901a\u77e5\u8ba1\u5212\u8fdb\u884c\uff0c\u8fd9\u610f\u5473\u7740Imugene\u5fc5\u987b\u901a\u77e5HREC\u6279\u51c6\u7684\u6cbb\u7597\u836f\u54c1\u7ba1\u7406\u5c40\uff0c\u5e76\u5b8c\u6210\u5f53\u5730\u7684\u542f\u52a8\u6d3b\u52a8\u3002<\/p>\n<p>Imugene\u516c\u53f8\u8868\u793a\uff0c\u9884\u8ba1\u5c06\u4e8e\u4eca\u5e748\u6708\u5f00\u59cb\u5bf9\u60a3\u8005\u8fdb\u884c\u7b5b\u67e5\u3002<\/p>\n<p>\u636e\u8be5\u516c\u53f8\u4ecb\u7ecd\uff0cPD1-Vaxx\u7684\u7b2c\u4e00\u9636\u6bb5\u591a\u4e2d\u5fc3\u3001\u5242\u91cf\u9012\u589e\u7814\u7a76\u5c06\u6d89\u53ca32\u540d\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\uff0c\u533b\u5b66\u7814\u7a76\u4eba\u5458\u8ba1\u5212\u6d4b\u8bd5\u4e0d\u540c\u5242\u91cf\u7684PD1-Vaxx\u4f5c\u4e3a\u5355\u4e00\u7597\u6cd5\u548c\u7ed3\u5408\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\u836f\u7269\u3002<\/p>\n<h2>\u80ba\u764c\u7684\u8bca\u65ad<\/h2>\n<p>\u5728\u6700\u8fd1\u7684\u62a5\u544a\u4e2d\uff0c\u6fb3\u5927\u5229\u4e9a\u80ba\u57fa\u91d1\u4f1a\u4f30\u8ba1\u6bcf\u5e74\u5927\u7ea6\u670912800\u540d\u6fb3\u5927\u5229\u4e9a\u4eba\u88ab\u8bca\u65ad\u51fa\u80ba\u764c\u3002<\/p>\n<p>\u5728\u7f8e\u56fd\uff0c\u4e13\u5bb6\u4f30\u8ba1\u6bcf16\u4e2a\u4eba\u4e2d\u5c31\u6709\u4e00\u4e2a\u4f1a\u5728\u4ed6\u4eec\u7684\u4e00\u751f\u4e2d\u88ab\u8bca\u65ad\u51fa\u80ba\u764c\u3002\u7f8e\u56fd\u6bcf\u5e74\u7ea6\u670922.5\u4e07\u4eba\u88ab\u8bca\u65ad\u51fa\u80ba\u764c\uff0c\u6bcf2.3\u5206\u949f\u5c31\u6709\u4e00\u4e2a\u65b0\u8bca\u65ad\u3002<\/p>\n<p>\u80bf\u7624\u5b66\u516c\u53f8\u8868\u793a,\u5176PD1-Vaxx\u5019\u9009\u4eba\u662f\u4e00\u4e2aB\u7ec6\u80de\u764c\u75c7\u514d\u75ab\u7597\u6cd5\u7528\u4e8e\u6cbb\u7597\u80bf\u7624,\u5982\u80ba\u764c\u901a\u8fc7\u5e72\u6270\u6240\u8c13\u201cPD-1 \/ PD-L1\u7ed1\u5b9a\u548c\u4e92\u52a8\u201d,\u5e76\u4ea7\u751f\u4e00\u79cd\u6297\u764c\u6548\u679c\u7c7b\u4f3c\u4e8e\u4eba\u6027\u5316\u6297\u4f53Keytruda, Opdivo\u548c\u5404\u79cd\u5176\u4ed6\u514d\u75ab\u6291\u5236\u5242\u68c0\u67e5\u7ad9\u5c06\u764c\u75c7\u6cbb\u7597\u7684\u5355\u514b\u9686\u6297\u4f53\u3002<\/p>\n<p>Imugene\u7684\u8463\u4e8b\u603b\u7ecf\u7406\u517c\u9996\u5e2d\u6267\u884c\u5b98Leslie Chong\u8868\u793a\uff0c\u6559\u5b66\u548c\u8bf1\u5bfc\u4eba\u4f53\u4ea7\u751f\u81ea\u8eab\u9488\u5bf9PD1\u8868\u8fbe\u7ec6\u80de\u7684\u6297\u4f53\u7684\u6982\u5ff5\u4ee3\u8868\u4e86\u201c\u80bf\u7624\u5b66\u7684\u8303\u5f0f\u8f6c\u53d8\u201d\uff0c\u662f\u4e00\u79cd\u65b0\u7684\u764c\u75c7\u6cbb\u7597\u65b9\u6cd5\u3002<\/p>\n<p>\u8be5\u8bd5\u9a8c\u65e8\u5728\u786e\u5b9aPD1-Vaxx\u7684\u5b89\u5168\u6027\uff0c\u5305\u62ec\u6709\u6548\u6027\u3001\u8010\u53d7\u6027\u548c\u514d\u75ab\u5e94\u7b54\uff0c\u540c\u65f6\u4e5f\u8981\u786e\u5b9a\u4f5c\u4e3a\u5355\u4e00\u6cbb\u7597\u548c\u968f\u540e\u4e0e\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\u7ed3\u5408\u7684\u6700\u4f73\u751f\u7269\u5242\u91cf\u3002<\/p>\n<p>\u201c\u5bf9\u4e8eImugene\u548c\u4e34\u5e8a\u533b\u751f\u6cbb\u7597\u9762\u4e34\u80ba\u764c\u6311\u6218\u7684\u6fb3\u5927\u5229\u4e9a\u4eba\u6765\u8bf4\uff0c\u6211\u4eec\u6fb3\u5927\u5229\u4e9a\u7814\u7a76\u7684\u5f00\u59cb\u662f\u4e00\u4e2a\u91cd\u8981\u7684\u91cc\u7a0b\u7891\u3002\u5728\u7b2c\u4e00\u6b21\u6279\u51c6\u4e4b\u540e\u8fd9\u4e48\u5feb\u5c31\u83b7\u5f97\u7b2c\u4e8c\u6b21\u9053\u5fb7\u6279\u51c6\uff0c\u8fd9\u4ee4\u4eba\u5174\u594b\u3002\u201d<\/p>\n<p>\u201c\u6211\u4eec\u671f\u5f85\u5728\u6fb3\u5927\u5229\u4e9a\u548c\u7f8e\u56fd\u5ba3\u5e03\u66f4\u591a\u7684\u7f51\u7ad9\uff0c\u201d\u5979\u8865\u5145\u8bf4\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u514d\u75ab\u80bf\u7624\u516c\u53f8Imugene (ASX: IMU)\u53ca\u65f6\u83b7\u5f97\u4e86\u7b2c\u4e8c\u5c4a\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a(HREC)\u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u5f00\u59cb\u5176\u68c0\u67e5\u70b9\u514d\u75ab\u7597\u6cd5\u5019\u9009\u4ea7\u54c1PD1-Vaxx\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002 \u5c31\u5728\u4e09\u5929\u524d\uff0c\u8be5\u516c\u53f8\u5ba3\u5e03\u6536\u5230HREC\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u7684\u9996\u4efd\u6279\u51c6\uff0c\u8be5\u8bd5\u9a8c\u5c06\u5728\u6089\u5c3c\u7efc\u5408\u764c\u75c7\u533b\u9662Chris O &#8216;Brien Lifehouse\u8fdb\u884c\u3002 \u7b2c\u4e8c\u5bb6\u83b7\u5f97\u4f26\u7406\u8bb8\u53ef\u7684\u533b\u9662\u662f\u540c\u6837\u4f4d\u4e8e\u6089\u5c3c\u7684\u9ea6\u8003\u745e\u5927\u5b66\u533b\u9662\u3002Imugene\u8868\u793a\uff0c\u968f\u7740\u8be5\u516c\u53f8\u6700\u8fd1\u5411\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(Food and Drug Administration)\u63d0\u4ea4\u4e86\u65b0\u836f\u7814\u7a76\u62a5\u544a\uff0c\u516c\u53f8\u5f88\u5feb\u5c06\u5728\u6fb3\u5927\u5229\u4e9a\u548c\u7f8e\u56fd\u5f00\u8bbe\u66f4\u591a\u7684\u4e34\u5e8a\u57fa\u5730\u3002 \u8fd9\u7b14\u8d44\u91d1\u610f\u5473\u7740Imugene\u5df2\u7ecf\u6210\u529f\u901a\u8fc7\u4e86\u4f26\u7406\u5ba1\u6279\uff0c\u5e76\u8bc1\u5b9e\u8be5\u516c\u53f8\u5df2\u7ecf\u5b8c\u6210\u4e86PD1-Vaxx\u6240\u6709\u4f18\u79c0\u7684\u4e34\u5e8a\u524d\u5b89\u5168\u548c\u6709\u6548\u6027\u6d4b\u8bd5\uff0c\u53ef\u4ee5\u5f00\u59cb\u4eba\u4f53\u4e34\u5e8a\u8bd5\u9a8c\u3002 I\u671f\u8bd5\u9a8c\u7684\u6fb3\u5927\u5229\u4e9a\u90e8\u5206\u5c06\u6309\u7167\u6fb3\u5927\u5229\u4e9a\u7684\u4e34\u5e8a\u8bd5\u9a8c\u901a\u77e5\u8ba1\u5212\u8fdb\u884c\uff0c\u8fd9\u610f\u5473\u7740Imugene\u5fc5\u987b\u901a\u77e5HREC\u6279\u51c6\u7684\u6cbb\u7597\u836f\u54c1\u7ba1\u7406\u5c40\uff0c\u5e76\u5b8c\u6210\u5f53\u5730\u7684\u542f\u52a8\u6d3b\u52a8\u3002 Imugene\u516c\u53f8\u8868\u793a\uff0c\u9884\u8ba1\u5c06\u4e8e\u4eca\u5e748\u6708\u5f00\u59cb\u5bf9\u60a3\u8005\u8fdb\u884c\u7b5b\u67e5\u3002 \u636e\u8be5\u516c\u53f8\u4ecb\u7ecd\uff0cPD1-Vaxx\u7684\u7b2c\u4e00\u9636\u6bb5\u591a\u4e2d\u5fc3\u3001\u5242\u91cf\u9012\u589e\u7814\u7a76\u5c06\u6d89\u53ca32\u540d\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u60a3\u8005\uff0c\u533b\u5b66\u7814\u7a76\u4eba\u5458\u8ba1\u5212\u6d4b\u8bd5\u4e0d\u540c\u5242\u91cf\u7684PD1-Vaxx\u4f5c\u4e3a\u5355\u4e00\u7597\u6cd5\u548c\u7ed3\u5408\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\u836f\u7269\u3002 \u80ba\u764c\u7684\u8bca\u65ad \u5728\u6700\u8fd1\u7684\u62a5\u544a\u4e2d\uff0c\u6fb3\u5927\u5229\u4e9a\u80ba\u57fa\u91d1\u4f1a\u4f30\u8ba1\u6bcf\u5e74\u5927\u7ea6\u670912800\u540d\u6fb3\u5927\u5229\u4e9a\u4eba\u88ab\u8bca\u65ad\u51fa\u80ba\u764c\u3002 \u5728\u7f8e\u56fd\uff0c\u4e13\u5bb6\u4f30\u8ba1\u6bcf16\u4e2a\u4eba\u4e2d\u5c31\u6709\u4e00\u4e2a\u4f1a\u5728\u4ed6\u4eec\u7684\u4e00\u751f\u4e2d\u88ab\u8bca\u65ad\u51fa\u80ba\u764c\u3002\u7f8e\u56fd\u6bcf\u5e74\u7ea6\u670922.5\u4e07\u4eba\u88ab\u8bca\u65ad\u51fa\u80ba\u764c\uff0c\u6bcf2.3\u5206\u949f\u5c31\u6709\u4e00\u4e2a\u65b0\u8bca\u65ad\u3002 \u80bf\u7624\u5b66\u516c\u53f8\u8868\u793a,\u5176PD1-Vaxx\u5019\u9009\u4eba\u662f\u4e00\u4e2aB\u7ec6\u80de\u764c\u75c7\u514d\u75ab\u7597\u6cd5\u7528\u4e8e\u6cbb\u7597\u80bf\u7624,\u5982\u80ba\u764c\u901a\u8fc7\u5e72\u6270\u6240\u8c13\u201cPD-1 \/ PD-L1\u7ed1\u5b9a\u548c\u4e92\u52a8\u201d,\u5e76\u4ea7\u751f\u4e00\u79cd\u6297\u764c\u6548\u679c\u7c7b\u4f3c\u4e8e\u4eba\u6027\u5316\u6297\u4f53Keytruda, Opdivo\u548c\u5404\u79cd\u5176\u4ed6\u514d\u75ab\u6291\u5236\u5242\u68c0\u67e5\u7ad9\u5c06\u764c\u75c7\u6cbb\u7597\u7684\u5355\u514b\u9686\u6297\u4f53\u3002 Imugene\u7684\u8463\u4e8b\u603b\u7ecf\u7406\u517c\u9996\u5e2d\u6267\u884c\u5b98Leslie Chong\u8868\u793a\uff0c\u6559\u5b66\u548c\u8bf1\u5bfc\u4eba\u4f53\u4ea7\u751f\u81ea\u8eab\u9488\u5bf9PD1\u8868\u8fbe\u7ec6\u80de\u7684\u6297\u4f53\u7684\u6982\u5ff5\u4ee3\u8868\u4e86\u201c\u80bf\u7624\u5b66\u7684\u8303\u5f0f\u8f6c\u53d8\u201d\uff0c\u662f\u4e00\u79cd\u65b0\u7684\u764c\u75c7\u6cbb\u7597\u65b9\u6cd5\u3002 \u8be5\u8bd5\u9a8c\u65e8\u5728\u786e\u5b9aPD1-Vaxx\u7684\u5b89\u5168\u6027\uff0c\u5305\u62ec\u6709\u6548\u6027\u3001\u8010\u53d7\u6027\u548c\u514d\u75ab\u5e94\u7b54\uff0c\u540c\u65f6\u4e5f\u8981\u786e\u5b9a\u4f5c\u4e3a\u5355\u4e00\u6cbb\u7597\u548c\u968f\u540e\u4e0e\u514d\u75ab\u68c0\u67e5\u70b9\u6291\u5236\u5242\u7ed3\u5408\u7684\u6700\u4f73\u751f\u7269\u5242\u91cf\u3002 \u201c\u5bf9\u4e8eImugene\u548c\u4e34\u5e8a\u533b\u751f\u6cbb\u7597\u9762\u4e34\u80ba\u764c\u6311\u6218\u7684\u6fb3\u5927\u5229\u4e9a\u4eba\u6765\u8bf4\uff0c\u6211\u4eec\u6fb3\u5927\u5229\u4e9a\u7814\u7a76\u7684\u5f00\u59cb\u662f\u4e00\u4e2a\u91cd\u8981\u7684\u91cc\u7a0b\u7891\u3002\u5728\u7b2c\u4e00\u6b21\u6279\u51c6\u4e4b\u540e\u8fd9\u4e48\u5feb\u5c31\u83b7\u5f97\u7b2c\u4e8c\u6b21\u9053\u5fb7\u6279\u51c6\uff0c\u8fd9\u4ee4\u4eba\u5174\u594b\u3002\u201d \u201c\u6211\u4eec\u671f\u5f85\u5728\u6fb3\u5927\u5229\u4e9a\u548c\u7f8e\u56fd\u5ba3\u5e03\u66f4\u591a\u7684\u7f51\u7ad9\uff0c\u201d\u5979\u8865\u5145\u8bf4\u3002<\/p>\n","protected":false},"author":5,"featured_media":8646,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[458],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Imugene\u83b7\u5f97\u4e86\u65b0\u7684\u764c\u75c7\u514d\u75ab\u7597\u6cd5PD1-Vaxx\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53cc\u91cd\u6279\u51c6<\/title>\n<meta name=\"description\" content=\"\u514d\u75ab\u80bf\u7624\u516c\u53f8Imugene (ASX: IMU)\u53ca\u65f6\u83b7\u5f97\u4e86\u7b2c\u4e8c\u5c4a\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a(HREC)\u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u5f00\u59cb\u5176\u68c0\u67e5\u70b9\u514d\u75ab\u7597\u6cd5\u5019\u9009\u4ea7\u54c1PD1-Vaxx\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Imugene\u83b7\u5f97\u4e86\u65b0\u7684\u764c\u75c7\u514d\u75ab\u7597\u6cd5PD1-Vaxx\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53cc\u91cd\u6279\u51c6\" \/>\n<meta property=\"og:description\" content=\"\u514d\u75ab\u80bf\u7624\u516c\u53f8Imugene (ASX: IMU)\u53ca\u65f6\u83b7\u5f97\u4e86\u7b2c\u4e8c\u5c4a\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a(HREC)\u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u5f00\u59cb\u5176\u68c0\u67e5\u70b9\u514d\u75ab\u7597\u6cd5\u5019\u9009\u4ea7\u54c1PD1-Vaxx\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-17T02:44:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:02:01+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/07\/Imugene-ASX-IMU-Phase-1-clinical-trial-cancer-immunotherapy-PD1-Vaxx-Australia.jpg\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Imugene\u83b7\u5f97\u4e86\u65b0\u7684\u764c\u75c7\u514d\u75ab\u7597\u6cd5PD1-Vaxx\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53cc\u91cd\u6279\u51c6\" \/>\n<meta name=\"twitter:description\" content=\"\u514d\u75ab\u80bf\u7624\u516c\u53f8Imugene (ASX: IMU)\u53ca\u65f6\u83b7\u5f97\u4e86\u7b2c\u4e8c\u5c4a\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a(HREC)\u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u5f00\u59cb\u5176\u68c0\u67e5\u70b9\u514d\u75ab\u7597\u6cd5\u5019\u9009\u4ea7\u54c1PD1-Vaxx\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/07\/Imugene-ASX-IMU-Phase-1-clinical-trial-cancer-immunotherapy-PD1-Vaxx-Australia.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx\/\",\"name\":\"Imugene\u83b7\u5f97\u4e86\u65b0\u7684\u764c\u75c7\u514d\u75ab\u7597\u6cd5PD1-Vaxx\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53cc\u91cd\u6279\u51c6\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-07-17T02:44:58+00:00\",\"dateModified\":\"2023-08-29T18:02:01+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u514d\u75ab\u80bf\u7624\u516c\u53f8Imugene (ASX: IMU)\u53ca\u65f6\u83b7\u5f97\u4e86\u7b2c\u4e8c\u5c4a\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a(HREC)\u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u5f00\u59cb\u5176\u68c0\u67e5\u70b9\u514d\u75ab\u7597\u6cd5\u5019\u9009\u4ea7\u54c1PD1-Vaxx\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Imugene\u83b7\u5f97\u4e86\u65b0\u7684\u764c\u75c7\u514d\u75ab\u7597\u6cd5PD1-Vaxx\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53cc\u91cd\u6279\u51c6\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Imugene\u83b7\u5f97\u4e86\u65b0\u7684\u764c\u75c7\u514d\u75ab\u7597\u6cd5PD1-Vaxx\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53cc\u91cd\u6279\u51c6","description":"\u514d\u75ab\u80bf\u7624\u516c\u53f8Imugene (ASX: IMU)\u53ca\u65f6\u83b7\u5f97\u4e86\u7b2c\u4e8c\u5c4a\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a(HREC)\u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u5f00\u59cb\u5176\u68c0\u67e5\u70b9\u514d\u75ab\u7597\u6cd5\u5019\u9009\u4ea7\u54c1PD1-Vaxx\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Imugene\u83b7\u5f97\u4e86\u65b0\u7684\u764c\u75c7\u514d\u75ab\u7597\u6cd5PD1-Vaxx\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53cc\u91cd\u6279\u51c6","og_description":"\u514d\u75ab\u80bf\u7624\u516c\u53f8Imugene (ASX: IMU)\u53ca\u65f6\u83b7\u5f97\u4e86\u7b2c\u4e8c\u5c4a\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a(HREC)\u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u5f00\u59cb\u5176\u68c0\u67e5\u70b9\u514d\u75ab\u7597\u6cd5\u5019\u9009\u4ea7\u54c1PD1-Vaxx\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx\/","og_site_name":"smallcapsCN","article_published_time":"2020-07-17T02:44:58+00:00","article_modified_time":"2023-08-29T18:02:01+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/07\/Imugene-ASX-IMU-Phase-1-clinical-trial-cancer-immunotherapy-PD1-Vaxx-Australia.jpg"}],"author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"Imugene\u83b7\u5f97\u4e86\u65b0\u7684\u764c\u75c7\u514d\u75ab\u7597\u6cd5PD1-Vaxx\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53cc\u91cd\u6279\u51c6","twitter_description":"\u514d\u75ab\u80bf\u7624\u516c\u53f8Imugene (ASX: IMU)\u53ca\u65f6\u83b7\u5f97\u4e86\u7b2c\u4e8c\u5c4a\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a(HREC)\u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u5f00\u59cb\u5176\u68c0\u67e5\u70b9\u514d\u75ab\u7597\u6cd5\u5019\u9009\u4ea7\u54c1PD1-Vaxx\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/07\/Imugene-ASX-IMU-Phase-1-clinical-trial-cancer-immunotherapy-PD1-Vaxx-Australia.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx\/","url":"https:\/\/smallcapscn.x5view.co\/imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx\/","name":"Imugene\u83b7\u5f97\u4e86\u65b0\u7684\u764c\u75c7\u514d\u75ab\u7597\u6cd5PD1-Vaxx\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53cc\u91cd\u6279\u51c6","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-07-17T02:44:58+00:00","dateModified":"2023-08-29T18:02:01+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u514d\u75ab\u80bf\u7624\u516c\u53f8Imugene (ASX: IMU)\u53ca\u65f6\u83b7\u5f97\u4e86\u7b2c\u4e8c\u5c4a\u4eba\u7c7b\u7814\u7a76\u4f26\u7406\u59d4\u5458\u4f1a(HREC)\u7684\u6279\u51c6\uff0c\u5728\u6fb3\u5927\u5229\u4e9a\u5f00\u59cb\u5176\u68c0\u67e5\u70b9\u514d\u75ab\u7597\u6cd5\u5019\u9009\u4ea7\u54c1PD1-Vaxx\u7684\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/imugene-approval-phase-1-clinical-trial-new-cancer-immunotherapy-pd1-vaxx\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Imugene\u83b7\u5f97\u4e86\u65b0\u7684\u764c\u75c7\u514d\u75ab\u7597\u6cd5PD1-Vaxx\u4e00\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53cc\u91cd\u6279\u51c6"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1574"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1574"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1574\/revisions"}],"predecessor-version":[{"id":8645,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/1574\/revisions\/8645"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/8646"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}